$323.27
arrow_drop_down0.13%Key Stats | |
---|---|
Open | $322.88 |
Prev. Close | $322.14 |
EPS | 57.78 |
Dividend | Non-Dividend |
Next Earnings Date | - |
Dividend Yield % | - |
LOW | HIGH | |
---|---|---|
Day Range | 322.17 | 324.09 |
52 Week Range | 229.57 | 348.48 |
Ratios | |
---|---|
EPS | 57.78 |
Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.
Period: Next 12 Months
•Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.
Enstar Completes Loss Portfolio Transfer With SiriusPoint
Enstar Announces Expiration of "Go-Shop" Period
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates RCM, ESGR on Behalf of Shareholders
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Revance Therapeutics, Inc. (Nasdaq – RVNC), Greenbrook TMS, Inc. (OTC – GBNHF), R1 RCM Inc. (Nasdaq - RCM), Enstar Group Limited (Nasdaq – ESGR)
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: R1 RCM Inc. (Nasdaq - RCM), Enstar Group Limited (Nasdaq – ESGR), Premier Financial Corp. (Nasdaq – PFC), The First Bancshares, Inc. (NYSE – FBMS)
Enstar Completes Reinsurance Transaction with Accredited